aac6-Ib

UniProt ID: A0A076UB44
Organism: Enterobacter cloacae
Review Status: DRAFT
Aliases:
AAC(6')-Ib8 AAC(6')-I Aminoglycoside N(6')-acetyltransferase type 1
📝 Provide Detailed Feedback

Gene Description

AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase (EC 2.3.1.82) of the GNAT acetyltransferase superfamily. It transfers an acetyl group from acetyl-CoA to the 6'-amino group of 4,6-disubstituted aminoglycosides (e.g. kanamycin, amikacin, tobramycin, netilmicin), abolishing their binding to the 16S rRNA A-site and conferring aminoglycoside resistance by drug inactivation. AAC(6')-Ib is the most prevalent aminoglycoside acetyltransferase in Gram-negative clinical isolates and is typically carried as a gene cassette in class 1 integrons on plasmids; numbered allelic variants (here -Ib8) differ by point substitutions.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0016407 acetyltransferase activity
IEA
GO_REF:0000104
MODIFY
Summary: Correct but over-general. The specific characterised activity is aminoglycoside 6'-N-acetyltransferase activity (GO:0047663, EC 2.3.1.82), which is already annotated.
Reason: Over-general parent of the specific GO:0047663 already present on this entry; the specific term should be used.
GO:0016740 transferase activity
IEA
GO_REF:0000104
MODIFY
Summary: Root-level transferase term derived from the UniProt 'Transferase' keyword; uninformative given the specific GO:0047663 annotation.
Reason: Far too general (keyword-derived); subsumed by the specific aminoglycoside 6'-N-acetyltransferase activity.
GO:0016747 acyltransferase activity, transferring groups other than amino-acyl groups
IEA
GO_REF:0000002
MODIFY
Summary: Correct but over-general (InterPro-derived); the specific 6'-N-acetyltransferase activity is the appropriate molecular function.
Reason: Over-general parent; replace with GO:0047663.
GO:0046677 response to antibiotic
IEA
GO_REF:0000117
ACCEPT
Summary: AAC(6')-Ib8 confers aminoglycoside resistance by acetylating (inactivating) the drug; 'response to antibiotic' is the appropriate biological process for a resistance enzyme.
Reason: Standard, well-supported BP for an antibiotic-modifying resistance enzyme; consistent with the CARD 'antibiotic inactivation' mechanism for ARO:3002579.
Supporting Evidence:
PMID:18710261
Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides.
GO:0047663 aminoglycoside 6'-N-acetyltransferase activity
IEA
GO_REF:0000003
ACCEPT
Summary: The specific, correct molecular function (EC 2.3.1.82): acetyl-CoA-dependent acetylation of the 6'-amino group of aminoglycosides (e.g. kanamycin B -> N(6')-acetylkanamycin B). This is the core function and exactly matches the EC and CARD AAC(6')-Ib family assignment.
Reason: EC 2.3.1.82-derived specific MF, consistent with the UniProt catalytic-activity reaction (kanamycin B + acetyl-CoA = N(6')-acetylkanamycin B + CoA), the AAC(6')-Ib family (CARD ARO:3002579), and the InterPro N6_acetyl_AAC6 signature (IPR030971). Retain as the core function.
Supporting Evidence:
PMID:18710261
Observation of the direct, and optimally positioned, interaction between the 6'-NH
GO:0005737 cytoplasm
IDA
PMID:18710261
Mechanistic and structural analysis of aminoglycoside N-acet...
NEW
Summary: AAC(6')-Ib is a soluble GCN5-related N-acetyltransferase (GNAT) that uses cytoplasmic acetyl-CoA; it was expressed and purified as a soluble enzyme and structurally characterized. The expected cellular location is the cytoplasm; GOA carried no location term.
Reason: Soluble cytoplasmic acetyltransferase using the cytoplasmic cofactor acetyl-CoA; adding the cellular component makes the annotation set complete.
Supporting Evidence:
PMID:18710261
The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2

Core Functions

AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase: it transfers an acetyl group from acetyl-CoA to the 6'-amino group of 4,6-disubstituted aminoglycosides, inactivating the drug and conferring aminoglycoside resistance.

Directly Involved In:
Cellular Locations:
Substrates:
Supporting Evidence:
  • PMID:18710261
    Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides.

References

Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant.
  • AAC(6')-Ib is a regioselective aminoglycoside N-acetyltransferase; such enzymes are the predominant cause of bacterial aminoglycoside resistance. It acetylates the 6'-amino group, with Asp115 acting as the general base.
    "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
  • AAC(6')-Ib-wt was expressed and purified as a soluble protein and its three-dimensional structure solved in complex with donor (CoA) and acceptor (aminoglycoside) ligands, defining the catalytic mechanism.
    "The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2"
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.
  • A variant of AAC(6')-Ib (AAC(6')-Ib-cr, bearing Trp102Arg and Asp179Tyr) acquires the ability to N-acetylate fluoroquinolones (ciprofloxacin), reducing their activity.
    "ciprofloxacin in clinical bacterial isolates conferred by a variant of the gene encoding aminoglycoside acetyltransferase AAC(6')-Ib"
Gene Ontology annotation through association of InterPro records with GO terms
Gene Ontology annotation based on Enzyme Commission mapping
Gene Ontology annotation by UniProt keywords
Electronic Gene Ontology annotations created by ARBA machine learning models

Suggested Questions for Experts

Q: Does AAC(6')-Ib8 carry any of the substitutions (e.g. Trp102Arg/Asp179Tyr) that, in the AAC(6')-Ib-cr variant, extend activity to fluoroquinolones, or is it a 'classical' aminoglycoside-only enzyme?

Suggested Experiments

Experiment: Determine acetylation kinetics (kcat/Km) against a panel of 4,6-aminoglycosides (kanamycin, amikacin, tobramycin, netilmicin) with acetyl-CoA, and test ciprofloxacin to exclude AAC(6')-Ib-cr activity.

📄 View Raw YAML

id: A0A076UB44
gene_symbol: aac6-Ib
aliases:
- "AAC(6')-Ib8"
- "AAC(6')-I"
- Aminoglycoside N(6')-acetyltransferase type 1
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:550
  label: Enterobacter cloacae
description: >-
  AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase (EC 2.3.1.82) of the GNAT acetyltransferase
  superfamily. It transfers an acetyl group from acetyl-CoA to the 6'-amino group of 4,6-disubstituted
  aminoglycosides (e.g. kanamycin, amikacin, tobramycin, netilmicin), abolishing their binding to the
  16S rRNA A-site and conferring aminoglycoside resistance by drug inactivation. AAC(6')-Ib is the most
  prevalent aminoglycoside acetyltransferase in Gram-negative clinical isolates and is typically carried
  as a gene cassette in class 1 integrons on plasmids; numbered allelic variants (here -Ib8) differ by
  point substitutions.
references:
- id: PMID:18710261
  title: "Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant."
  findings:
  - statement: >-
      AAC(6')-Ib is a regioselective aminoglycoside N-acetyltransferase; such enzymes are the
      predominant cause of bacterial aminoglycoside resistance. It acetylates the 6'-amino group, with
      Asp115 acting as the general base.
    supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
  - statement: >-
      AAC(6')-Ib-wt was expressed and purified as a soluble protein and its three-dimensional structure
      solved in complex with donor (CoA) and acceptor (aminoglycoside) ligands, defining the catalytic
      mechanism.
    supporting_text: "The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified (Vetting et al., Biochemistry 2008; PMC2855648, full text). Kinetic and structural
      characterization of AAC(6')-Ib (and the -cr variant); directly supports the 6'-N-acetyltransferase
      activity and the soluble GNAT-fold enzyme.
- id: PMID:16369542
  title: "Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase."
  findings:
  - statement: >-
      A variant of AAC(6')-Ib (AAC(6')-Ib-cr, bearing Trp102Arg and Asp179Tyr) acquires the ability to
      N-acetylate fluoroquinolones (ciprofloxacin), reducing their activity.
    supporting_text: "ciprofloxacin in clinical bacterial isolates conferred by a variant of the gene encoding aminoglycoside acetyltransferase AAC(6')-Ib"
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified (Robicsek et al., Nat Med 2006). Describes the AAC(6')-Ib-cr fluoroquinolone-active
      variant; relevant to whether this allele (-Ib8) is a classical aminoglycoside-only enzyme.
- id: GO_REF:0000002
  title: "Gene Ontology annotation through association of InterPro records with GO terms"
  findings: []
- id: GO_REF:0000003
  title: "Gene Ontology annotation based on Enzyme Commission mapping"
  findings: []
- id: GO_REF:0000104
  title: "Gene Ontology annotation by UniProt keywords"
  findings: []
- id: GO_REF:0000117
  title: "Electronic Gene Ontology annotations created by ARBA machine learning models"
  findings: []
existing_annotations:
- term:
    id: GO:0016407
    label: acetyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000104
  qualifier: enables
  review:
    summary: >-
      Correct but over-general. The specific characterised activity is aminoglycoside
      6'-N-acetyltransferase activity (GO:0047663, EC 2.3.1.82), which is already annotated.
    action: MODIFY
    reason: >-
      Over-general parent of the specific GO:0047663 already present on this entry; the specific term
      should be used.
    proposed_replacement_terms:
    - id: GO:0047663
      label: aminoglycoside 6'-N-acetyltransferase activity
- term:
    id: GO:0016740
    label: transferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000104
  qualifier: enables
  review:
    summary: >-
      Root-level transferase term derived from the UniProt 'Transferase' keyword; uninformative given
      the specific GO:0047663 annotation.
    action: MODIFY
    reason: >-
      Far too general (keyword-derived); subsumed by the specific aminoglycoside 6'-N-acetyltransferase
      activity.
    proposed_replacement_terms:
    - id: GO:0047663
      label: aminoglycoside 6'-N-acetyltransferase activity
- term:
    id: GO:0016747
    label: acyltransferase activity, transferring groups other than amino-acyl groups
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Correct but over-general (InterPro-derived); the specific 6'-N-acetyltransferase activity is the
      appropriate molecular function.
    action: MODIFY
    reason: >-
      Over-general parent; replace with GO:0047663.
    proposed_replacement_terms:
    - id: GO:0047663
      label: aminoglycoside 6'-N-acetyltransferase activity
- term:
    id: GO:0046677
    label: response to antibiotic
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: involved_in
  review:
    summary: >-
      AAC(6')-Ib8 confers aminoglycoside resistance by acetylating (inactivating) the drug; 'response
      to antibiotic' is the appropriate biological process for a resistance enzyme.
    action: ACCEPT
    reason: >-
      Standard, well-supported BP for an antibiotic-modifying resistance enzyme; consistent with the
      CARD 'antibiotic inactivation' mechanism for ARO:3002579.
    supported_by:
    - reference_id: PMID:18710261
      supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
- term:
    id: GO:0047663
    label: aminoglycoside 6'-N-acetyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000003
  qualifier: enables
  review:
    summary: >-
      The specific, correct molecular function (EC 2.3.1.82): acetyl-CoA-dependent acetylation of the
      6'-amino group of aminoglycosides (e.g. kanamycin B -> N(6')-acetylkanamycin B). This is the core
      function and exactly matches the EC and CARD AAC(6')-Ib family assignment.
    action: ACCEPT
    reason: >-
      EC 2.3.1.82-derived specific MF, consistent with the UniProt catalytic-activity reaction
      (kanamycin B + acetyl-CoA = N(6')-acetylkanamycin B + CoA), the AAC(6')-Ib family (CARD
      ARO:3002579), and the InterPro N6_acetyl_AAC6 signature (IPR030971). Retain as the core function.
    supported_by:
    - reference_id: PMID:18710261
      supporting_text: "Observation of the direct, and optimally positioned, interaction between the 6'-NH"
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:18710261
  qualifier: located_in
  review:
    summary: >-
      AAC(6')-Ib is a soluble GCN5-related N-acetyltransferase (GNAT) that uses cytoplasmic acetyl-CoA;
      it was expressed and purified as a soluble enzyme and structurally characterized. The expected
      cellular location is the cytoplasm; GOA carried no location term.
    action: NEW
    reason: >-
      Soluble cytoplasmic acetyltransferase using the cytoplasmic cofactor acetyl-CoA; adding the
      cellular component makes the annotation set complete.
    supported_by:
    - reference_id: PMID:18710261
      supporting_text: "The three-dimensional structure of AAC(6')-Ib-wt was determined in various complexes with donor and acceptor ligands to resolutions greater than 2.2"
core_functions:
- description: >-
    AAC(6')-Ib8 is an aminoglycoside 6'-N-acetyltransferase: it transfers an acetyl group from
    acetyl-CoA to the 6'-amino group of 4,6-disubstituted aminoglycosides, inactivating the drug and
    conferring aminoglycoside resistance.
  molecular_function:
    id: GO:0047663
    label: aminoglycoside 6'-N-acetyltransferase activity
  directly_involved_in:
  - id: GO:0046677
    label: response to antibiotic
  locations:
  - id: GO:0005737
    label: cytoplasm
  substrates:
  - id: CHEBI:57288
    label: acetyl-CoA
  supported_by:
  - reference_id: PMID:18710261
    supporting_text: "Enzymatic modification of aminoglycoside antibiotics mediated by regioselective aminoglycoside N-acetyltransferases is the predominant cause of bacterial resistance to aminoglycosides."
# CURATION NOTE (ARO->GO mapping QA): the ARO->GO mapping (ARO:3000121 'aminoglycoside acetyltransferase
# (AAC)' -> GO:0034069 'aminoglycoside N-acetyltransferase activity') would propose GO:0034069 for this
# entry. It is intentionally NOT added: GO:0034069 is the is_a PARENT of the existing, more specific
# GO:0047663 and would be a redundant over-annotation. This is the subsumption case flagged in the
# project spot review (the gain report should suppress a candidate when a more specific descendant is
# already annotated).
suggested_questions:
- question: >-
    Does AAC(6')-Ib8 carry any of the substitutions (e.g. Trp102Arg/Asp179Tyr) that, in the AAC(6')-Ib-cr
    variant, extend activity to fluoroquinolones, or is it a 'classical' aminoglycoside-only enzyme?
suggested_experiments:
- description: >-
    Determine acetylation kinetics (kcat/Km) against a panel of 4,6-aminoglycosides (kanamycin,
    amikacin, tobramycin, netilmicin) with acetyl-CoA, and test ciprofloxacin to exclude AAC(6')-Ib-cr
    activity.